newsfilter
← Latest News
GlobeNewswire·

NeuBase Therapeutics to Explore Strategic Alternatives

PITTSBURGH, Aug. 03, 2023 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology company developing Stealth Editors™ to perform in vivo gene editing without